Zevra Therapeutics's total assets for Q4 2024 were $178.13M, a decrease of -7.01% from the previous quarter. ZVRA total liabilities were $138.46M for the fiscal quarter, a 13.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.